anmelden
FTSE All-Share
5.796,02
PKT
+9,62
PKT
+0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | BAT Buy | Deutsche Bank AG | |
| 15.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 15.02.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.02.24 | BP Buy | UBS AG | |
| 14.02.24 | Unilever Sell | UBS AG | |
| 14.02.24 | Unilever Halten | DZ BANK | |
| 13.02.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 13.02.24 | BAT Neutral | UBS AG | |
| 13.02.24 | Glencore Outperform | RBC Capital Markets | |
| 13.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | AstraZeneca Halten | DZ BANK | |
| 12.02.24 | Unilever Market-Perform | Bernstein Research | |
| 12.02.24 | Diageo Sell | Deutsche Bank AG | |
| 12.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | BP Outperform | RBC Capital Markets | |
| 12.02.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | AstraZeneca Overweight | Barclays Capital | |
| 09.02.24 | GSK Buy | UBS AG | |
| 09.02.24 | AstraZeneca Sell | UBS AG | |
| 09.02.24 | Unilever Sell | UBS AG | |
| 09.02.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 09.02.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.02.24 | Unilever Overweight | Barclays Capital | |
| 09.02.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 09.02.24 | GSK Buy | Jefferies & Company Inc. | |
| 09.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.02.24 | Diageo Underperform | RBC Capital Markets | |
| 08.02.24 | GSK Buy | Deutsche Bank AG | |
| 08.02.24 | AstraZeneca Sell | UBS AG | |
| 08.02.24 | BAT Neutral | UBS AG | |
| 08.02.24 | Unilever Market-Perform | Bernstein Research | |
| 08.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 08.02.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.02.24 | Unilever Sector Perform | RBC Capital Markets | |
| 07.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 07.02.24 | BP Buy | UBS AG |
